Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people

Technology appraisal guidance
Reference number: TA300
Published: 27 November 2013

Hepatitis C (children and young people) - peginterferon alfa and ribavirin: final appraisal determination document

Hepatitis C (children and young people) - peginterferon alfa and ribavirin: final appraisal determination document

Hepatitis C (children and young people) - peginterferon alfa and ribavirin: final appraisal determination document
11 October 2013
(186.75 Kb 54 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 09 October 2013